ArticleInvestigational new drugs2011

The histone deacetylase inhibitor panobinostat demonstrates marked synergy with conventional chemotherapeutic agents in human ovarian cancer cell lines.

Daniel R Budman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.